Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

“Smiling” Bob?

This article was originally published in The Tan Sheet

Executive Summary

Enzyte marketer Berkeley Premium Nutraceuticals "has been able to reduce customer complaints by 90% and has held a steady average of less than two per week" during the past 24 months, the firm announces Sept. 6. The company has spent "well over $20 mil." to buy equipment and create the necessary departments to ensure total industry compliance, and has confirmed through four separate third-party surveys that customers are very satisfied with Berkeley brands. The firm recently paid $2.5 mil. in settlement and restitution costs in a consent agreement that arose from thousands of consumer complaints in six states (1"The Tan Sheet" March 6, 2006, p. 8)...

You may also be interested in...



Enzyte Marketer Berkeley Settles Complaints For $2.5 Mil.

Berkeley Premium Nutraceuticals will pay $2.5 mil. in legal costs and restitution in accordance with a consent agreement, the firm announced March 1

US FDA Urges COVID-19 Transmission Risk Mitigation In Cell And Gene Therapy Manufacturing

The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.

COVID-19: US Acted To Beat Other Countries To Next 1.25M Doses Of Regeneron Cocktail

Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.

Topics

UsernamePublicRestriction

Register

RS150923

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel